why choose us

First received: February 04, 2026

Clinical Trial: OPTIMISE-CKD Study_Dapagliflozin Effectiveness in CKD

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Chronic Kidney Disease

Study Type: OBSERVATIONAL


Official Title: A Multinational, Observational, Retrospective, Secondary Data Study Analyzing Dapagliflozin Effectiveness in Routine Clinical Practice Among Patients With Chronic Kidney Disease. Local Adaptation for

Brief Summary: This is a retrospective, observational study, using secondary data captured in electronic health records (EHRs). The study is a part of the OPTIMISE-CKD program to assess the current CKD treatment landscape, Dapagliflozin utilisation and characterization of incident CKD patient and the burden of disease within an observation period of 39 months (August 2020-November 2024) in two cohorts (preand post-reimbursement of Dapagliflozin for CKD)

Read more